The Latin America, Middle East and Africa Nephrostomy Devices Market would witness market growth of 9.06% CAGR during the forecast period (2019-2025). The incidence of ovarian, kidney, bladder and prostate cancer underscores the advantages of nephrostomy devices while lessening the composition of the therapy cost in several nations, governments and private organizations. Likewise, the focus is on initiatives that spread awareness about nephrostomy devices. The growth of the market is anticipated to give opportunities to such projects over the years to come.
PCNL is the most preferred minimally invasive technique. Over the years, advances in PCNL have been made in technology and instruments to reduce morbidity and improve efficiency. In the past, major morbidity has been correlated with urological complications following renal transplantation. These cases can now be managed with minimally invasive techniques by the development and application of endourological procedures. Tubeless mini-percutaneous nephrolithotomy (MILT) is one of the most effective ways to treat larger stones in the kidney.
Based on Product, the market is segmented into Guidewires, Sheath Dilators, Nephrostomy Catheters, Drainage Tubes and Other Nephrostomy Devices. Based on End Use, the market is segmented into Hospital, Ambulatory Surgical Centers (ASCs) and Emergency Clinics. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, Teleflex, Inc., Cook Medical, Inc. (Cook Group), Coloplast Group, Olympus Corporation, Argon Medical Devices, Inc., UreSil LLC, B. Braun Melsungen AG, Cardinal Health, Inc., and Becton, Dickinson and Company.
Market Segmentation:
By Product
By End Use
By Country
Companies Profiled
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.